In these subpopulation, a KIT D816V mutation was present in all the 13 patients with ISM (100%) and in the patient with ISM with an associated haematological neoplasm (100%), of the patients with MMAS 2 of the 6 patients presented the mutation (33%). Here, KIT is linked to hematopoietic and lymphoid cell neoplasm.